Real-time enrollment status for this patients with chemotherapy-induced thrombocytopenia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:48 AM UTC
| NCT Number | NCT07286032 |
| Recruiting Status | Recruiting |
| Condition | Patients With Chemotherapy-Induced Thrombocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Last Updated on CT.gov | April 30, 2026 (Apr 30, 2026) |
As of July 13, 2026: Clinical trial NCT07286032 is currently recruiting participants. This clinical trial study for patients with chemotherapy-induced thrombocytopenia is actively seeking new participants at 7 locations across the United States. The study is sponsored by Jiangsu HengRui Medicine Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07286032 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07286032 was last updated Apr 30, 2026 (April 30, 2026). HelloStudys verifies this status automatically.